The most common brain tumour glioblastoma, despite attempts to treat, is usually rapidly lethal (average survival 1–1.5 years) due to highly active glioblastoma stem cells with flexible metabolic needs. Here, in a mouse model, an enzyme called FAK is found to be key in controlling glioblastoma stem cell energy usage and presents a possible target for slowing down deadly cell growth
Read the published research article here
Written by
BPoD stands for Biomedical Picture of the Day. Managed by the MRC Laboratory of Medical Sciences until Jul 2023, it is now run independently by a dedicated team of scientists and writers. The website aims to engage everyone, young and old, in the wonders of biology, and its influence on medicine. The ever-growing archive of more than 4000 research images documents over a decade of progress. Explore the collection and see what you discover. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.